Molecularly Imprinted Polymers as Artificial Antibodies in Therapeutic Applications

In recent years, the fields of tissue engineering and drug delivery have witnessed remarkable progress, driven by the pursuit of enhancing therapeutic outcomes and addressing a wide range of medical challenges. Among the cutting-edge technologies that have captured considerable attention in this domain are Molecularly Imprinted Polymers (MIPs). These sophisticated biomaterials have undergone significant advancements in both their applications and synthesis processes since their initial proposal five decades ago. Molecular imprinting, a highly effective synthetic technique, lies at the core of MIPs’ ability to create durable materials with predetermined molecular selectivity. Often referred to as “artificial antibodies,” MIPs possess unique qualities that render them intriguing candidates for various applications, particularly in tissue engineering and targeted drug delivery. The incorporation of novel capabilities into MIPs has further augmented their potential, enabling responsiveness to diverse environmental conditions and facilitating selective molecular binding. This adaptability allows for precise adjustments in binding and controlled release of various molecular targets, while also streamlining the process of affinity separation. While the molecular imprinting of various substances has proved successful, cells have emerged as particularly challenging targets. Early research predominantly focused on microprinting techniques, but recent advancements have steered away from this approach, opting for epitope imprinting to develop MIP nanoparticles (NPs). Moreover, the obstacles encountered in MIP manufacture during the early stages have been effectively resolved through the development of innovative techniques such as solid-phase MIP synthesis. The present study highlights the pivotal developments in the creation and utilization of molecularly imprinted polymers that possess the distinctive ability to specifically recognize physiologically active substances. The underlying concepts supporting the design of these highly effective and template-specific molecularly imprinted polymers take center stage in this exploration. Notably, the emphasis is placed on the imprinting of intricate macromolecular and supramolecular templates, showcasing the versatility and precision of these synthetic materials. In the realm of chemistry and molecular biology, considerable attention is given to the current and potential applications of molecularly imprinted polymers. Their promising uses span a broad spectrum, ranging from advanced imaging techniques and targeted medication delivery to diagnostics and the field of tissue engineering, where MIPs demonstrate immense potential. In conclusion, this article provides a succinct summary of numerous cell imprinting techniques, underscoring the significance of molecularly imprinted polymers in pushing the boundaries of tissue engineering and drug delivery. As research in this area continues to evolve, MIPs remain at the forefront of groundbreaking technologies, poised to revolutionize the medical landscape and improve the lives of countless individuals worldwide.